Europe — EMA
Mizollen (Mizolastine)
GNH USA supplies Mizollen (Mizolastine), a selective H1‑receptor antihistamine indicated for allergic rhinitis and urticaria.
Request sourcing
What is Mizolastine?
Mizolastine, the active ingredient in Mizollen, is an antihistamine presented as a tablet for oral use. It treats allergic rhinitis and urticaria by blocking peripheral H1‑receptors in patients with seasonal or chronic allergies.
GNH USA supplies Mizollen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Mizolastine used for?
Mizolastine is an H1‑receptor antagonist used in allergic conditions.
Allergic rhinitis: reduces nasal congestion, sneezing and itching associated with seasonal or perennial allergies. Urticaria: alleviates itching and hives by preventing histamine‑mediated skin reactions.
What are the side effects of Mizolastine?
Mizollen may cause a range of adverse reactions, most of which are mild and reversible.
Common Side Effects: - Drowsiness - Headache - Dry mouth - Fatigue
Serious or Rare Side Effects: - Anaphylaxis (severe allergic reaction) - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatic enzyme elevation or liver dysfunction
What precautions apply to Mizolastine?
Before prescribing Mizollen, clinicians should consider several safety aspects.
Assess renal function: adjust use in patients with severe renal impairment. Monitor for sedation: advise caution when driving or operating machinery. Avoid alcohol: concurrent use may increase central nervous system depression. Use with caution in hepatic disease: limited data on patients with liver dysfunction. Store at ambient temperature: keep in the original pack, protect from moisture.
What does Mizolastine interact with?
Mizollen can interact with other medicines, requiring attention to avoid adverse outcomes.
Major Interactions (Avoid): - CYP3A4 inhibitors: may raise mizolastine plasma concentrations. - CNS depressants: additive sedation risk. - Alcohol: enhances drowsiness and impairment.
Moderate Interactions (Monitor Closely):\n- Anticholinergic drugs: may worsen dry‑mouth effects. - Other antihistamines: risk of cumulative sedation.



